Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PRESSRELEASE 15 november 2018 Saniona, (OMX: SANION), ett ledande biomedicinbolag inom jonkanaler, meddelar idag att dess partner, Cadent Therapeutics, har initierat en fas 2a-studie för essentiell...
-
PRESS RELEASE 15 November 2018 Saniona (OMX: SANION), a leading biotech company within ion-channel research, announced today that its partner, Cadent Therapeutics, has initiated a Phase 2a study for...
-
PRESSMEDDELANDE 14 november 2018 Finansiella nyckeltal Jan – sep 2018 (jan - sep 2017) Nettoomsättning 52,7 MSEK (16,1)EBIT -19,9 MSEK (-40,6)Periodens resultat -17,7 MSEK (-34,4)Resultat per...
-
PRESS RELEASE November 14, 2018 Financial highlights Jan – Sep 2018 (Jan - Sep 2017) Net revenues were SEK 52.7 M (16.1 M)EBIT was SEK -19.9 M (-40.6 M)Net profit/loss was SEK -17.7 M...
-
PRESSMEDDELANDE 8 november 2018 Saniona, ett ledande biomedicinbolag inom jonkanaler, meddelade idag att bolaget har ingått ett 1-årigt köpoptionsavtal med Initiator Pharma A/S, som ger Initiator...
-
PRESS RELEASE November 8, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has entered into a 1-year option agreement with Initiator Pharma A/S, where...
-
PRESSMEDDELANDE 4 oktober 2018 Saniona, ett ledande bioteknikbolag inom jonkanaler, meddelar idag att bolaget har slutfört rekryteringen av de planerade tonåriga patienterna till andra delen av...
-
PRESS RELEASE October 4, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has completed the planned recruitment of adolescents for the second part of its...
-
PRESSMEDDELANDE 1 oktober 2018 Saniona, ett ledande biomedicinbolag inom jonkanalsforskning, meddelade idag att deras spin-out Scandion Oncology har godkänts för notering på Spotlight Stock Market....
-
PRESS RELEASE October 1, 2018 Saniona, a leading biotech company within ion-channel research, today announced that the spin-out company Scandion Oncology has been approved for listing at the...